AstraZeneca invests “tens of millions” into Cheshire, UK manufacturing site
August 29, 2017Manufacturing and Production, Research and Development AZ, AstraZeneca, Cheshire, Chesire, UK, life sciences, pharma, pharmaceuticals
AstraZeneca has announced plans to invest a multi-million sum into its £150 million facility in Macclesfield, Chesire, UK – a …
Lithium levels in water supply could prevent dementia
August 25, 2017Research and Development biotech, drugs, lithium, pharma, pharmaceutical
Lithium has long been used in the treatment of people living with bipolar disorder and animal studies have found potential …
Top Ten most popular articles on Pharmafile.com this week
August 25, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing life sciences, medicine, pharma, pharmaceutical, top ten
As much as it might try, the pharmaceutical industry just isn’t able to keep the drug pricing debate out of …
The pharmacovigilance market dynamic
August 25, 2017Medical Communications biotech, drugs, pharma, pharmaceutical, pharmacoviglance
Pharmacovigilance is a science of understanding drug safety through identification, assessment, and prevention of adverse drug reactions (ADRs). It is …
Seven years later, EC gives approval for Merck KGaA’s MS drug
August 25, 2017Medical Communications, Sales and Marketing Mavenclad, Merck KGaA, biotech, drugs, multiple sclerosis, pharma, pharmaceutical
In 2011, Merck KGaA had all but given up on its MS drug after having been knocked back by both …
Samsung completes hat-trick of big biosimilar approvals
August 25, 2017Medical Communications, Sales and Marketing Biogen, Samsung Bioepis, biosimilars, biotech, drugs, pharma, pharmaceutical
Samsung Bioepis has announced that it, alongside its partner Biogen, has secured European Commission approval for its biosimilar version of …
‘Trade secret information’ to be shared between EMA and FDA
August 25, 2017Manufacturing and Production, Medical Communications EMA, FDA, biotech, drugs, pharma, pharmaceutical
As part of the on-going harmonisation of manufacturing standards across the Atlantic, the EMA and FDA have announced that they …
Roche receives FDA Priority Review for drug with potted history
August 24, 2017Sales and Marketing Roche, biotech, drugs, emicizumab, pharma, pharmaceutical
Roche, alongside its subsidiary, Genentech, announced that it has received Priority Review for its haemophilia A drug, emicizumab, and that …
Extended use of AstraZeneca’s Brilinta reduces cardiovascular death risk
August 24, 2017Research and Development AstraZeneca, Brilinta, cardiovascular, heart attack, life sciences, pharma, pharmaceutical
New data for AstraZeneca’s blood thinner Brilinta (ticagrelor) has shown that extended use of the drug can cut the risk …
HIV home tests seized from market over potential risk
August 24, 2017Sales and Marketing HIV, MHRA, biotech, drugs, pharma, pharmaceutical
The MHRA has removed over 100 HIV home testing kits from two UK based suppliers, after they were found not …
Novartis names new Chief Digital Officer
August 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, appointment, digital pharma, life sciences, pharma, pharmaceuticals
Novartis has announced that it has appointed a new Chief Digital Officer in the form of Bertrand Bodson, who will …
Novartis gets EU nod for potential blockbuster breast cancer drug
August 24, 2017Sales and Marketing CDK4/6, Novartis, biotech, breast cancer, drugs, pharma, pharmaceutical
Novartis has released that it has received marketing approval from the European Commission for its drug for the treatment of …
Janssen opposes use of its drug in state execution
August 23, 2017Medical Communications, Research and Development, Sales and Marketing Janssen, etomidate, life sciences, pharma, pharmaceutical
Janssen has spoken out against plans to use an anaesthetic drug it invented over 50 years ago to execute prisoners, …
Collaboration between Lilly and CRUK progresses to clinical trials
August 23, 2017Research and Development Cancer Research UK, biotech, drugs, pharma, pharmaceutical
Cancer Research UK has announced that its collaboration with Eli Lilly for the treatment of advanced solid tumours will progress …
Scientists discover ‘Achilles’ heel’ of oesophageal cancer
August 23, 2017Research and Development ICR, Janssen, biotech, drugs, pharma, pharmaceutical
Researchers from The Institute of Cancer Research have potentially found a new use for Imbruvica, after discovering a weakness in …
Novartis launches first large-scale smartphone-based study in multiple sclerosis
August 23, 2017Research and Development MS, Novartis, life sciences, multiple sclerosis, pharma, pharmaceuticals
Novartis has launched what it claims is the first large-scale mobile research study which will gather data on multiple sclerosis …
Ultragenyx stumbles in P3 trial for severe muscle disease
August 23, 2017Research and Development Ultragenyx, biotech, drugs, pharma, pharmaceutical
Ultragenyx has revealed results from a Phase 3 trial into the treatment of GNE myopathy showed that its compound did …
Research unveils new drug targets for more effective treatment of liver disease
August 22, 2017Manufacturing and Production, Research and Development life sciences, liver, liver cancer, liver disease, pharma, pharmaceuticals
Researchers from KTH The Royal Institute of Technology and Gothenburg University have identified new drug targets in the treatment of …
AstraZeneca strikes mRNA-based partnership in respiratory disease
August 22, 2017Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Ethris, MedImmune, mrna, pharma, pharmaceuticals
AstraZeneca and MedImmune, the company’s biologics research arm, have forged a five year research partnership with mRNA-based pulmonary disease specialist …
Hikma risks a stratospheric 430% price increase on product
August 22, 2017Manufacturing and Production, Sales and Marketing Hikma, biotech, drugs, generics, pharma, pharmaceutical
It wasn’t so long ago that pharmaceutical companies could change the prices of its products with little scrutiny. A series …
Latest content
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
